AI assistant
Dare Bioscience, Inc. — Director's Dealing 2016
Oct 27, 2016
34825_dirs_2016-10-27_253c4ce1-293d-4b2d-843f-d192fc992ee8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-10-25
Reporting Person: Eliasof Scott (SVP, Chief Scientific Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| EmployeeStock Option (right to buy) | $5.0776 | 2017-08-09 | Common Stock (3446) | Direct | |
| Employee Stock Option (right to buy) | $5.948 | 2018-07-07 | Common Stock (517) | Direct | |
| Employee Stock Option (right to buy) | $5.948 | 2019-03-26 | Common Stock (586) | Direct | |
| Employee Stock Option (right to buy) | $3.3367 | 2020-03-04 | Common Stock (655) | Direct | |
| Emplyee Stock Option (right to buy) | $3.3367 | 2021-01-27 | Common Stock (9953) | Direct | |
| Emplyee Stock Option (right to buy) | $3.7719 | 2022-01-24 | Common Stock (13786) | Direct | |
| Emplpyee Stock Option (right to buy) | $3.917 | 2022-12-18 | Common Stock (19707) | Direct | |
| Employee Stock Option (right to buy) | $10.5904 | 2024-01-09 | Common Stock (13786) | Direct | |
| Employee Stock Option (right to buy) | $5.73 | 2024-06-23 | Common Stock (58400) | Direct | |
| Employee Stock Option (right to buy) | $8.16 | 2025-02-04 | Common Stock (43000) | Direct | |
| Employee Stock Option (right to buy) | $3.29 | 2015-11-30 | Common Stock (158000) | Direct | |
| Employee Stock Option (right to buy) | $3.04 | 2026-01-04 | Common Stock (42500) | Direct | |
| Employee Stock Option (right to buy) | $1.14 | 2026-08-21 | Common Stock (75000) | Direct |
Footnotes
F1: This option was granted on August 10, 2007 and vested over four years, with 25% of the shares vesting on the first anniversary of May 2, 2007 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F2: This option was granted on July 8, 2008 and vested over four years, with 25% of the shares vesting on the first anniversary of January 1, 2008 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F3: This option was granted on March 27, 2009 and vested over four years, with 25% of the shares vesting on the first anniversary of January 1, 2009 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F4: This option was granted on January 28, 2011 and vested over four years, with 25% of the shares vesting on the first anniversary of December 31, 2010 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F5: This option was granted on January 28, 2011 and vested over four years, with 25% of the shares vesting on the first anniversary of December 31, 2009 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F6: This option was granted on January 25, 2012 and vested over four years, with 25% of the shares vesting on the first anniversary of December 31, 2011 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F7: This option was granted on December 19, 2012 and is scheduled to vest over four years, with 25% of the shares vesting on the first anniversary of December 31, 2012 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
F8: This option was granted on January 10, 2014. The shares underlying the option are scheduled to vest in equal monthly installments over four years from the vesting commencement date of January 31, 2014.
F9: This option was granted on June 24, 2014. The shares underlying the option are scheduled to vest in equal monthly installments over four years from the grant date.
F10: This option was granted on February 5, 2015. The shares underlying the option are scheduled to vest in equal monthly installments over four years from the vesting commencement date of January 31, 2015.
F11: This option was granted on December 1, 2015. The shares underlying the option are scheduled to vest in three equal installments on December 1, 2016, December 1, 2017 and December 1, 2018.
F12: This option was granted on January 5, 2016. The shares underlying the option are scheduled to vest in equal monthly installments over four years from the vesting commencement date of January 1, 2016.
F13: This option was granted on August 22, 2016. The shares underlying this option are scheduled to vest in equal installments every six months from the grant date until the second anniversary of the grant date.